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Abstract 
Background: Diabetes has become a major health problem worldwide, as well as in South Africa. This, coupled with the chronicity of the disease, 
relate to an increasing burden on health care facilities and an increasing number of hospital admissions of patients suffering from diabetes. 
Admissions are mostly related to diabetes itself, but the frequency of admissions for problems not related to diabetes is increasing as the prevalence 
of diabetes increases in the population. Proper inpatient glycaemic management is important for improving patient outcome and for reducing the 
risk of inpatient complications.
Objectives: The objective of this study was to evaluate current practices in the care of diabetic inpatients as well as to assess the glycaemic control 
that is achieved during hospitalisation.
Methods: An audit was done of clinical hospital records of adult diabetic patients admitted to Kalafong Hospital, a large secondary hospital in South 
Africa. All patients admitted who had type 1 or type 2 diabetes before admission, or who were newly diagnosed on admission or in hospital were 
included, irrespective of the discipline to which the patient was admitted. All patient admissions in the eight-month period preceding the initiation of 
the audit were included.
Results: The hospital records of 164 diabetic patients were audited. With regard to glucose monitoring, 60.8% of patients had irregular and erratic 
glucose monitoring, 37.2% had regular (either four- or six-hourly) monitoring and only 2% were monitored in relation to meals. Of the 164 patients, 
160 were not fasting, 27 were treated with an insulin sliding scale at some stage during their admission, and in 14 (52%) of the patients who were 
on sliding scales the scale was used inappropriately. Most hospital inpatients with diabetes, i.e. 48 (30.4%), were treated with oral agents only; 29 
(18.4%) were treated with oral agents plus a daily dose of NPH insulin and 17 (10.8%) with mixed insulin twice daily. Only three patients (1.9%) 
received insulin supplemental to their regimen. The glycaemic control treatment schedule was appropriate in only 19.5% of cases.
Conclusions: Based on our findings, the monitoring and management of blood glucose in patients with diabetes during hospitalisation in a large 
secondary hospital in South Africa is currently inadequate. This calls for an educational intervention for doctors and nurses working with diabetic 
inpatients as well as the introduction of a blood glucose management protocol.
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Introduction
Diabetes has reached epidemic proportions worldwide,1 resulting 
in increased hospital admissions for patients with diabetes. In one 
United Kingdom hospital, the proportion of hospitalisations of patients 
with diabetes increased from 7.0% in 1991 to 11.1% in 2003.2 Health 
insurance data in the United States indicates that diabetic patients also 
tend to be admitted 2.4 times more frequently and that their hospital stay 
is 30% longer than for non-diabetic patients.3
Numerous studies have been published on the advantages of good 
glycaemic control and associated improved outcomes. This relates mostly 
to more rapid recovery from infections,4 shorter intensive care stays with 
reduced mortality,5 improved prognosis after myocardial infarction,6,7 less 
deep wound sepsis8 and fewer nosocomial infections.9,10 According to 
the American College of Endocrinology,9 one way of achieving improved 
glycaemic control is to implement a standardised inpatient management 
protocol. Information on inpatient glycaemic control and methods of 
achieving control in diabetic patients admitted to South African hospitals 
are currently not available in the literature.
The aim of this study was to assess the status of glycaemic control and 
methods utilised in the inpatient management of diabetes in a large 
secondary hospital. The need for the introduction of a standardised 
inpatient diabetes management protocol was also assessed.
Methods
Study population
A cross-sectional audit was done of hospital records of diabetic inpatients. 
All patients were older than 13 years of age and were non-fasting at 
some stage during hospitalisation. All hospitalisations occurred during 
the eight months preceding the audit. Specific attention was paid to the 
methods of inpatient glycaemic monitoring and glucose control. Hospital 
records were audited independent of the reason for admission or the 
severity of the disease.
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Data collection
Only information relating to the last hospitalisation was evaluated. 
Evaluation focused on the appropriateness of the method of glycaemic 
control for individual patients, the level of control of blood glucose and 
hypertension, evaluation of diabetes-related complications, and risk 
factors. The frequency of blood glucose and blood pressure measurements 
as well as the duration of hospital stay were noted. Diabetes follow-up 
arrangements upon discharge from hospital were also evaluated. The 
audit was done in a structured way after patient discharge, addressing 
the specific aspects mentioned above. Two independent observers 
audited all patient records.
Outcome measures
Outcome measures that were evaluated were: glycaemic control during 
hospitalisation as well as at time of discharge, time until glycaemic 
control after admission, hypertension control in hospital and at time 
of discharge, duration of hospital stay and patient outcome, and the 
frequency of in-hospital disease and treatment-related complications. 
Appropriateness of inpatient management of diabetes was based 
on the inpatient management guidelines of the American Diabetes 
Association.11 The criteria included three aspects for patients on insulin 
who were non-fasting: basal insulin, prandial insulin and supplemental 
or adjustment insulin. The appropriateness for inpatients on oral agents 
is unclear due to the scarcity of studies investigating the roles of various 
oral agents.12 For the study on which this article is based, use of oral 
agents was considered appropriate if non-fasting patients’ glycaemic 
control was good.
Data management
Data were captured electronically on Microsoft Access. Statistical 
analysis was done by using SPSS 14 for Windows (SPSS Inc, 1989–2005) 
statistical software. All descriptive data and proportions are reported 
as percentages and continuous variables are reported as means with 
standard deviations (SD) or, in the case of ordinal and skew data, as 
medians with inter-quartile ranges. Comparisons were done by using 
appropriate parametric or non-parametric tests dependent on the type 
and distribution of data.
Ethical issues
This study was done after ethics approval was obtained from the Ethics 
committee of the Faculty of Health Sciences of the University of Pretoria. 
All patient and treating physician identification information was removed 
from the data after the audit of clinical records was completed. 
Results
Patient and hospitalisation characteristics (Table I)
During the eight-month period, 164 patients with diabetes were admitted 
to Kalafong Hospital (a large secondary hospital in Gauteng, South Africa). 
The median duration of admission was 7.5 days with a range of 1 to 87 
days, and an inter-quartile range of 3 to 13 days. Only patients admitted to 
the adult units of the hospital (patients older than 13 years) were included 
in this audit. The mean age of patients at the time of admission was 58.5 
years with a SD of 15.3 years (a range of 13 to 86 years). Predominantly 
females (n = 119, 72.6%) were hospitalised. The mean age of females 
was higher than that of males although this was not statistically 
significant,  60.2 vs 54 years (p = 0.21). No significant difference was 
demonstrated in the duration of diabetes between the two gender 
categories, 6.2 vs. 5.4 years (p = 0.59). Of the 164 patient records 
audited, 103 mentioned the duration that patients had diabetes. The 
median duration of diabetes in hospitalised patients was 3.7 years 
with an inter-quartile range of 1.1 to 9.25 years. A major contributor to 
the skewness of the distribution of the duration of diabetes is the fact 
that 19 patients were newly diagnosed during the audited admission. 
Of note is that 3.9% of patients had had diabetes for more than 
20 years. Most patients were admitted to Internal Medicine (medical) units 
(97 patients, i.e. 59.1%). Two patients were admitted to the ICU first and 
then transferred to Internal Medicine. The admission to the ICU in both 
cases was for medical reasons.
Table I: Patient demographics
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Inpatient deaths
Most patients improved (76.8%), but a significant proportion of patients 
died during hospitalisation (7.3%): two males and 10 females. Of the 
12 patients who died, three died of chronic renal failure, three of end-
stage heart failure, two had acute coronary syndromes of which one 
was complicated by diabetic keto-acidosis (DKA), one died of pulmonary 
tuberculosis, one of hypoglycaemic brain injury, one patient died after a 
femur fracture and one patient had a diabetic foot with sepsis. The mean 
age of patients who died was higher, although non-significant, namely 
66 years in comparison to 57.9 years in the case of those who left the 
hospital alive (p = 0.73). No statistically significant difference in the 
duration of diabetes could be demonstrated between patients who died 
(5.8 years) and those who were discharged alive (5.94 years) (p = 0.96).
Newly diagnosed patients
Nineteen of the 164 patients admitted were diagnosed with diabetes for 
the first time during hospitalisation. Of these, three patients presented 
with DKA, three were admitted with symptoms of diabetes, one patient 
had a stroke, three had foot ulcers, three presented with infections 
and one patient each with bowel obstruction, miscarriage and femur 
fracture.
Inpatient treatment (Figure 1)
Only four patients (2.4%) were kept nil per mouth at some stage during 
hospitalisation, and two patients (1.2%) received tube feeding. Of the 
four patients who were nil per mouth, three were treated with an insulin 
sliding scale and one received oral agents. Of the two patients who 
received tube feeding, one was on twice-daily insulin, and one did not 
receive any anti-diabetic treatment. The latter patient was however only 
controlled on diet before admission.
Most non-fasting patients were treated with oral agents (48 patients, 
30.4%). Twenty-nine patients (18.4%) were treated with oral agents and 
once-a-day NPH-insulin. Thirteen per cent of patients, who were non-
fasting, were on a regular insulin sliding scale only (20 patients). Twice-
daily mixed insulin was prescribed to 17 patients (10.8%). Only three 
patients (1.9%) received meal-related supplemental insulin in addition 
to their treatment regimen. Fifteen patients (9.1%) were documented 
to have received an insulin infusion at some stage during admission. 
Twelve of them had DKA and received insulin infusions as part of the DKA 
treatment regimen. One patient was admitted with a stroke, one with 
renal failure and one patient received cancer chemotherapy.
Twenty-seven patients (16.5%) were on an insulin sliding scale only, at 
some stage during hospitalisation. Insulin sliding scales were utilised 
as follows in the various departments: Internal Medicine 15 patients 
(15.5%), surgery nine patients (22.5%) and orthopaedics three patients 
(27.3%). Fifty-two per cent (14 of 27) of patients on insulin sliding scales 
received it inappropriately because they were non-fasting. Of these, 
eight were from Internal Medicine and six from surgical disciplines.
Appropriateness of treatment to control blood glucose
The inpatient diabetes treatment schedule was considered appropriate 
in 32 (19.5%) and inappropriate in 110 (67.1%) of the 164 patients. 
In 22 (13.4%) of the patient hospital records audited, insufficient 
information was available, making it impossible to decide if treatment 
was appropriate or not.
Inpatient glycaemic monitoring
Most inpatients (60.8%) had their blood glucose checked irregularly and 
haphazardly by ward staff. This could have been due to the lack of a 
ward schedule for testing blood glucose, or failure on the part of doctors 
to prescribe appropriate orders. About one-third had their blood glucose 
tested regularly according to a timed schedule, either four hourly or six 
hourly. Only three (2%) patients had their blood glucose tested in relation 
to meal consumption. 
Hypoglycaemic events
Of the 164 patients admitted to hospital, ten were admitted with 
hypoglycaemia. In six cases, hypoglycaemia was corrected before 
the patients left the emergency unit. No hypoglycaemic events were 
recorded in patients admitted for hypoglycaemia after the third day of 
hospitalisation. Of the 154 patients not hospitalised for hypoglycaemia, 
45 (29.2%) had at least one hypoglycaemic episode while in hospital. 
Of these, 20 patients (13%) had one episode, four had two hypoglycaemic 
episodes and 21 patients had three or more hypoglycaemic events 
during their hospital stay. No differences in the number of hypoglycaemic 
events could be demonstrated between patients on different treatment 
regimens.
Inpatient glycaemic control
The mean blood glucose on the first day of admission was 10.4 mmol/l 
(SD 4.2) with a range of 3.8 to 25.6 mmol/l. This improved to 8.53 mmol/l 
(SD 3.4) on the last day of hospitalisation. This improvement is 
statistically significant (p = < 0.001, paired sample t-test). This relates 
to a mean difference in blood glucose from the first to 
the last day of hospitalisation of 2.37 mmol/l (95% CI: 
1.78 to 2.95). An HbA1c (glycated haemoglobin) was 
done on 71 (43.3%) patients at the time of admission. 
The mean HbA1c value for these patients was 
11.3% (SD 4.3). In 67 (40.9%) patients hospitalised 
with diabetes, glycaemic control was achieved. 
For this purpose, control was defined as all blood glucose 
measurements for 24 hours monitored to be between 
3.5 and 10 mmol/l.
Inpatient blood pressure control
Thirty-nine per cent of patients were hypertensive on 
admission and received antihypertensive therapy in 
hospital. The mean systolic blood pressure improved 
from 131 mmHg on the first day of hospitalisation to 
125.4 mmHg on the last day of hospitalisation (p = < 
0.001). This relates to a mean reduction in systolic 
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blood pressure of 5.61 mmHg (95% CI: 2.37 to 8.85). Diastolic blood 
pressure improved from a mean of 78.1 to 76.6 mmHg (p = 0.004), 
which represents a mean improvement of 1.47 mmHg (95% CI: -0.84 
to -3.78).
Patient follow up and readmissions
From the audit of patient records, 70.7% referred to follow-up 
arrangements made for patients. It is uncertain for which proportion of 
these patients arrangements were made for follow up of diabetes or the 
primary presenting problem. 
Of the 164 patients, 31 (18.9%) were readmitted to hospital within six 
months after discharge. This was due to various reasons; only four 
(12.9%) were readmitted for glycaemic control, three (9.6%) for foot 
problems, seven (22.6%) for eye problems, of which four readmissions 
were for cataract surgery on a second eye, four patients were readmitted 
for cancer chemotherapy, four for follow-up surgical procedures and five 
for other chronic medical problems.
Discussion
The results of the study on which this article is based show that 
glycaemic control in a significant proportion of diabetic inpatients is 
still sub-optimal, with only 40.9% achieving control. Hypoglycaemic 
events occurred frequently, as 29.2% of inpatients had at least one 
hypoglycaemic event in hospital. The mean blood glucose improved 
significantly during admission: from more than 10 mmol/l on the first 
day of hospitalisation to 8.53 mmol/l on the last day of hospitalisation. 
The monitoring of blood glucose in diabetic inpatients is not optimal due 
to the erratic and irregular monitoring schedule in 60.8% of patients. 
Time-based monitoring, that is four or six hourly, is appropriate for 
patients who are fasting or who receive continuous tube feeds or total 
parenteral feeding, but not for patients who receive meals. Only six of the 
164 patients (3.6%) were fasting or received tube feeding, in which case 
time-based monitoring would be appropriate, but time-based monitoring 
was utilised in only 37.2% of the patients. The optimal monitoring 
schedule in at least 158 of the 164 diabetic inpatients would have been 
meal-related. Thus, at the time of this study only three patients (2%) 
were monitored optimally.11,13
The optimal way of treating hospitalised non-fasting diabetic patients 
would be to administer the patients’ usual treatment, with adjustment 
to compensate for a more fixed and regulated hospital diet. In addition, 
patients should receive meal-related supplemental insulin according to 
blood glucose levels. The administration of insulin according to a four- to 
six-hourly sliding scale in patients who are receiving meals in hospital 
is inappropriate.14 This audit indicated that sliding scales were still used 
inappropriately in 14 of the 164 patients. 
Several limitations hampered this study. Firstly, this audit did not include 
any admission of paediatric patients, thus the findings are only applicable 
to patients older than 13 years of age who are admitted to adult hospital 
units. Secondly, the audit was done in only one large secondary hospital 
with limited resources. The assumption was made that it is typical of 
circumstances in similar hospitals in South Africa. This hospital serves a 
large community of mostly medically uninsured patients of lower socio-
economic status. 
The findings of this audit are congruent with other studies from other 
parts of the world. An audit done at the Mayo clinic15 indicated that 11% 
of patients had at least one hypoglycaemic event during admission, and 
71% of patients had at least one blood glucose measurement higher 
than 11.1 mmol/l. A study done at a tertiary care facility in India16 
showed that glycaemic control was achieved in 48%, was sub-optimal 
in 15%, and poor in 37% of hospitalised diabetic patients. In a study by 
Cook et al,17 the mean duration of hospital stay for diabetic patients was 
5.7 days and most admissions to hospital were for cardiovascular (33%), 
endocrine and metabolic (13%), as well as for infective conditions (14%). 
The average duration of hospital stay for diabetic patients in the study by 
Jiang et al was 6.8 days for patients who had a single hospitalisation in 
comparison to 7.4 days in patients with multiple admissions.18 This study 
also reported that 30% of diabetic patients had two or more admissions 
over a period of one year. In a Spanish study, the mean duration of 
hospital admission was 11.4 days for diabetic patients.1 In a UK study, the 
mean duration of hospital stay was 19 days (range 1–300+) compared 
to the median length of stay of all hospital patients of 10 days.1 The 
management of diabetes in this UK study was considered inappropriate 
in 29% of patients who were not referred to a diabetes management 
team. The same study also indicated that 28% of patients were treated 
with diet alone, 52% with oral hypoglycaemic agents, 15% with insulin 
only and 5% with a combination of insulin and oral agents.
The American College of Endocrinology advises that the upper limit for 
glycaemic control in hospitalised diabetic patients should be 6.1 mmol/l 
pre-prandial and 10.0 mmol/l maximal.13 This target is currently not 
achieved in most patients in this audit as well as in numerous patients 
reported in other studies. The guideline is clear and methods to achieve 
this target should be developed and implemented. Probably the most 
important way to achieve glycaemic control is through proper education 
and training of physicians and nurses, implementation of adequate 
blood glucose monitoring schedules and protocols for management of 
hyperglycaemia.
The overall finding of this audit is that the inpatient management of 
diabetes by means of glucose monitoring and glycaemic control is 
currently inadequate. Doctors and nurses caring for diabetic inpatients 
should be educated in the management of diabetes, and proper protocols 
for inpatient management should be implemented.
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